Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Scientific Reports
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. scientific reports
  3. articles
  4. article
Falcarindiol alleviates airway inflammation and oxidative stress in asthma through Nrf2 pathway activation
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 21 February 2026

Falcarindiol alleviates airway inflammation and oxidative stress in asthma through Nrf2 pathway activation

  • Xiuhua Jiang1 na1,
  • Shengxiu Lai2 na1,
  • Zhen Lin1,
  • Fuhuang Lai1 &
  • …
  • Huifang Wu1 

Scientific Reports , Article number:  (2026) Cite this article

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Cell biology
  • Diseases
  • Drug discovery
  • Immunology
  • Medical research

Abstract

Oxidative stress and Th2-type immune responses play pivotal roles in asthma pathogenesis. Falcarindiol (FAD), a natural polyacetylene compound, exhibits promising anti-inflammatory and antioxidant properties, yet its therapeutic mechanism and efficacy in asthma treatment remain to be explored. An ovalbumin (OVA)-induced murine asthma model and IL-13-stimulated human bronchial epithelial cells (BEAS-2B) were employed to investigate FAD’s therapeutic mechanisms. Airway inflammation, oxidative stress markers, and Nrf2 pathway activation were comprehensively evaluated through hematoxylin and eosin (H&E) staining, ELISA, flow cytometry, and Western blotting. To establish mechanistic causality, the Nrf2 inhibitor ML385 and targeted shRNA knockdown approaches were used to validate the essential role of Nrf2 activation in mediating FAD’s protective effects. In OVA-induced asthmatic mice, FAD (100 or 200 mg/kg) produced dose-dependent therapeutic benefits, significantly reducing inflammatory scores, decreasing airway wall and smooth muscle thickness, substantially lowering serum IgE levels, and diminishing eosinophil infiltration in bronchoalveolar lavage fluid (BALF). Additionally, FAD effectively ameliorated oxidative stress, while simultaneously suppressing pro-inflammatory cytokine release. In IL-13-stimulated BEAS-2B cells, FAD dose-dependently protected against apoptosis and restored proliferation capacity while robustly activating the Nrf2/HO-1/NQO1 pathway. Mechanistic validation studies revealed that both ML385-mediated Nrf2 inhibition and Nrf2 shRNA knockdown largely abrogated FAD’s protective effects. FAD exerts anti-asthmatic effects through Nrf2 pathway activation, effectively mitigating airway inflammation, oxidative stress, and epithelial injury, establishing it as a promising therapeutic candidate for asthma.

Data availability

The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Abbreviations

ANOVA:

Analysis of variance

ARE:

Antioxidant response element

BALF:

Bronchoalveolar lavage fluid

BCA:

Bicinchoninic acid

BSA:

Bovine serum albumin

CAT:

Catalase

CCK:

8-cell counting Kit-8

DAPI:

4′,6-diamidino-2-phenylindole

DEX:

Dexamethasone

ECL:

Enhanced chemiluminescence

EdU:

5-ethynyl-2′-deoxyuridine

ELISA:

Enzyme-linked immunosorbent assay

FAD:

Falcarindiol

FBS:

Fetal bovine serum

FITC:

Fluorescein isothiocyanate

GSH:

Px-Glutathione peroxidase

H&E:

Hematoxylin and eosin

HO:

1-Heme oxygenase-1

HRP:

Horseradish peroxidase

HSD:

Honest significant difference

IgE:

Immunoglobulin E

IL:

Interleukin

Keap1:

Kelch-like ECH-associated protein 1

MDA:

Malondialdehyde

NQO1:

NAD(P)H quinone dehydrogenase 1

Nrf2/NRF2:

Nuclear factor erythroid 2-related factor 2

OVA:

Ovalbumin

Pbm:

Perimeter of basement membrane

PBS:

Phosphate-buffered saline

PI:

Propidium iodide

PVDF:

Polyvinylidene fluoride

RIPA:

Radioimmunoprecipitation assay

SD:

Standard deviation

SDS:

PAGE-Sodium dodecyl sulfate-polyacrylamide gel electrophoresis

shRNA:

Short hairpin RNA

SOD:

Superoxide dismutase

TCM:

Traditional Chinese medicine

TdT:

Terminal deoxynucleotidyl transferase

TNF:

α-tumor necrosis factor alpha

TUNEL:

Terminal deoxynucleotidyl transferase dUTP nick end labeling

Wall/Pbm:

Airway wall thickness to perimeter ratio

Wasm/Pbm:

Airway smooth muscle thickness to perimeter ratio

WHO:

World Health Organization

References

  1. Gans, M. D. & Gavrilova, T. Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes. Paediatr. Respir Rev. 36, 118–127 (2020).

    Google Scholar 

  2. Miller, R. L., Grayson, M. H. & Strothman, K. Advances in asthma: New understandings of asthma’s natural history, risk factors, underlying mechanisms, and clinical management. J. Allergy Clin. Immunol. 148 (6), 1430–1441 (2021).

    Google Scholar 

  3. Cazzola, M. et al. Asthma and comorbidities: Recent advances. Pol. Arch. Intern. Med. 132 (4), 16250 (2022).

    Google Scholar 

  4. Bosi, A. et al. Acute severe asthma: Management and treatment. Minerva Med. 112 (5), 605–614 (2021).

    Google Scholar 

  5. Papadopoulos, N. G., Miligkos, M. & Xepapadaki, P. A current perspective of allergic asthma: From mechanisms to management. Handb. Exp. Pharmacol. 268, 69–93 (2022).

    Google Scholar 

  6. Komlosi, Z. I. et al. Cellular and molecular mechanisms of allergic asthma. Mol. Aspects Med. 85, 100995 (2022).

    Google Scholar 

  7. Holgate, S. T. et al. Asthma. Nat. Rev. Dis. Primers 1(1):15025. (2015).

    Google Scholar 

  8. Scadding, G. K. & Scadding, G. W. Innate and adaptive immunity in allergic airway disease. Curr. Opin. Allergy Clin. Immunol. 22 (1), 10–15 (2022).

    Google Scholar 

  9. Noel, J. C. & Berin, M. C. Role of innate immunity and myeloid cells in susceptibility to allergic disease. Ann. N Y Acad. Sci. 1499 (1), 42–53 (2021).

    Google Scholar 

  10. Minnicozzi, M., Sawyer, R. T. & Fenton, M. J. Innate immunity in allergic disease. Immunol. Rev. 242 (1), 106–127 (2011).

    Google Scholar 

  11. Audousset, C., McGovern, T. & Martin, J. G. Role of Nrf2 in disease: Novel molecular mechanisms and therapeutic approaches—Pulmonary disease/asthma. Front. Physiol. 12, 727806 (2021).

    Google Scholar 

  12. Li, L. et al. Protective effect of astaxanthin on ochratoxin A-induced kidney injury to mice by regulating oxidative stress-related NRF2/KEAP1 pathway. Molecules 25 (6), 1386 (2020).

    Google Scholar 

  13. Xu, C. et al. Pterostilbene suppresses oxidative stress and allergic airway inflammation through AMPK/Sirt1 and Nrf2/HO-1 pathways. Immun. Inflamm. Dis. 9 (4), 1406–1417 (2021).

    Google Scholar 

  14. Wang, Y. et al. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury. Redox Biol. 51, 102262 (2022).

    Google Scholar 

  15. Park, K. R. et al. Falcarindiol stimulates apoptotic and autophagic cell death to attenuate cell proliferation, cell division, and metastasis through the PI3K/AKT/mTOR/p70S6K pathway in human oral squamous cell carcinomas. Am. J. Chin. Med. 50 (1), 295–311 (2022).

    Google Scholar 

  16. Wyrembek, P. et al. Falcarindiol allosterically modulates GABAergic currents in cultured rat hippocampal neurons. J. Nat. Prod. 75 (4), 610–616 (2012).

    Google Scholar 

  17. Ghanadian, M. et al. Bioassay-directed isolation of falcarindiol and isoacetovanillon from pycnocycla caespitosa based on KCl-induced contraction in rat uterus smooth muscles. Res. Pharm. Sci. 12 (3), 249–256 (2017).

    Google Scholar 

  18. Deding, U. et al. Effect of oral intake of carrot juice on cyclooxygenases and cytokines in healthy human blood stimulated by lipopolysaccharide. Nutrients 15 (3), 632 (2023).

    Google Scholar 

  19. Ohnuma, T. et al. Activation of the Nrf2/ARE pathway via S-alkylation of cysteine 151 in the chemopreventive agent-sensor Keap1 protein by falcarindiol, a conjugated diacetylene compound. Toxicol. Appl. Pharmacol. 244 (1), 27–36 (2010).

    Google Scholar 

  20. Ohnuma, T. et al. Dietary diacetylene falcarindiol induces phase 2 drug-metabolizing enzymes and blocks carbon tetrachloride-induced hepatotoxicity in mice through suppression of lipid peroxidation. Biol. Pharm. Bull. 34 (3), 371–378 (2011).

    Google Scholar 

  21. Meng, Z. et al. Potential cellular endocrinology mechanisms underlying the effects of Chinese herbal medicine therapy on asthma. Front. Endocrinol. (Lausanne). 13, 916328 (2022).

    Google Scholar 

  22. Wang, W. et al. Active ingredients from Chinese medicine plants as therapeutic strategies for asthma: Overview and challenges. Biomed. Pharmacother. 137, 111383 (2021).

    Google Scholar 

  23. Yuan, J. Y. et al. Research progress on icariin, a traditional Chinese medicine extract, in the treatment of asthma. Allergol. Immunopathol. (Madr). 50 (1), 9–16 (2022).

    Google Scholar 

  24. Andersen, C. B. et al. Falcarindiol purified from carrots leads to elevated levels of lipid droplets and upregulation of peroxisome proliferator-activated receptor-gamma gene expression in cellular models. Front. Pharmacol. 11, 565524 (2020).

    Google Scholar 

  25. Kan, S. et al. Synergistic activity of the combination of falcarindiol and itraconazole in vitro against dermatophytes. Front. Cell. Infect. Microbiol. 13, 1128000 (2023).

    Google Scholar 

  26. Kobaek-Larsen, M. et al. Effect of the dietary polyacetylenes falcarinol and falcarindiol on the gut microbiota composition in a rat model of colorectal cancer. BMC Res. Notes. 11 (1), 411 (2018).

    Google Scholar 

  27. Takahashi, S., Okaze, H. & Kawamoto, S. Falcarindiol promotes beige adipocyte-related gene expression and mitochondrial respiration in human preadipocyte-derived adipocytes. Cytotechnology 77 (4), 125 (2025).

    Google Scholar 

  28. Shi, Z. et al. Falcarindiol suppresses malignant progression and induces ferroptosis in Non-Small cell lung cancer by regulating JAK/STAT3 axis. J. Biochem. Mol. Toxicol. 39 (9), e70486 (2025).

    Google Scholar 

  29. Cao, L. et al. Falcarindiol improves functional recovery and alleviates neuroinflammation after spinal cord injury by inhibiting STAT/MAPK signaling pathways. Biochem. Biophys. Res. Commun. 736, 150860 (2024).

    Google Scholar 

  30. Bazan-Socha, S. et al. Increased oxidative stress in asthma-relation to inflammatory blood and lung biomarkers and airway remodeling indices. Biomedicines 10 (7), 1499 (2022).

    Google Scholar 

  31. Shen, G. et al. Association of life’s essential 8 and asthma: Mediating effect of inflammation and oxidative stress. J. Asthma. 62 (2), 328–335 (2025).

    Google Scholar 

  32. Alfurayhi, R., Huang, L. & Brandt, K. Pathways affected by falcarinol-type polyacetylenes and implications for their anti-inflammatory function and potential in cancer chemoprevention. Foods 12 (6), 1192 (2023).

    Google Scholar 

  33. Kobaek-Larsen, M. et al. Dietary polyacetylenic oxylipins falcarinol and falcarindiol prevent inflammation and colorectal neoplastic transformation: A mechanistic and dose-response study in a rat model. Nutrients 11 (9), 2223 (2019).

    Google Scholar 

  34. Venkatesan, T. et al. Falcarindiol inhibits LPS-induced inflammation via attenuating MAPK and JAK-STAT signaling pathways in murine macrophage RAW 264.7 cells. Mol. Cell. Biochem. 445 (1–2), 169–178 (2018).

    Google Scholar 

  35. Mitsui, S. et al. The herbal medicine compound falcarindiol from notopterygii rhizoma suppresses dendritic cell maturation. J. Pharmacol. Exp. Ther. 333 (3), 954–960 (2010).

    Google Scholar 

  36. Kim, T. W. & Ko, S. G. A novel PPARγ modulator falcarindiol mediates ER stress-mediated apoptosis by regulating NOX4 and overcomes radioresistance in breast cancer. Antioxidants (Basel). 13 (12), 1533 (2024).

    Google Scholar 

  37. Stefanson, A. L. & Bakovic, M. Falcarinol is a potent inducer of heme oxygenase-1 and was more effective than sulforaphane in attenuating intestinal inflammation at diet-achievable doses. Oxid. Med. Cell. Longev. 2018, 3153527 (2018).

    Google Scholar 

  38. Arisawa, K. et al. NRF2-dependent suppression of selenoprotein P expression promotes intracellular selenium metabolic remodeling and upregulation of antioxidant selenoproteins in hepatocellular carcinoma. Redox Biol. 86, 103821 (2025).

    Google Scholar 

  39. Ngo, V. & Duennwald, M. L. Nrf2 and oxidative stress: A general overview of mechanisms and implications in human disease. Antioxid. (Basel). 11 (12), 2345 (2022).

    Google Scholar 

  40. Rayees, S. et al. Therapeutic effects of R8, a semi-synthetic analogue of vasicine, on murine model of allergic airway inflammation via STAT6 Inhibition. Int. Immunopharmacol. 26 (1), 246–256 (2015). \.

    Google Scholar 

  41. Bukhari, S. I. et al. Safranal of Crocus sativus L. inhibits inducible nitric oxide synthase and attenuates asthma in a mouse model of asthma. Phytother Res. 29 (4), 617–627 (2015).

    Google Scholar 

Download references

Author information

Author notes
  1. Xiuhua Jiang and Shengxiu Lai contributed equally to this work.

Authors and Affiliations

  1. Department of Pediatrics, Longyan First Affiliated Hospital of Fujian Medical University, No.105 North Jiuyi Road, Xinluo District, Longyan City, 364000, Fujian Province, China

    Xiuhua Jiang, Zhen Lin, Fuhuang Lai & Huifang Wu

  2. Department of Pediatrics, Longyan Hospital of Traditional Chinese Medicine, Longyan, 364000, China

    Shengxiu Lai

Authors
  1. Xiuhua Jiang
    View author publications

    Search author on:PubMed Google Scholar

  2. Shengxiu Lai
    View author publications

    Search author on:PubMed Google Scholar

  3. Zhen Lin
    View author publications

    Search author on:PubMed Google Scholar

  4. Fuhuang Lai
    View author publications

    Search author on:PubMed Google Scholar

  5. Huifang Wu
    View author publications

    Search author on:PubMed Google Scholar

Contributions

XH Jiang, SX Lai and HF Wu contributed to literature review, study design, manuscript writing and critical reversion, and preparation of Figs. 1–7. Z Lin, and FH Lai were in charge of data extraction, analysis and interpretation. All authors read and agreed to this eventual version for publication.

Corresponding author

Correspondence to Huifang Wu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethical approval

This study was reviewed and approved by the Ethics Committee of Longyan First Hospital. Each experiment was performed in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals. The study was carried out in compliance with the ARRIVE guidelines (https://arriveguidelines.org).

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary Material 1

Supplementary Material 2

Supplementary Material 3

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, X., Lai, S., Lin, Z. et al. Falcarindiol alleviates airway inflammation and oxidative stress in asthma through Nrf2 pathway activation. Sci Rep (2026). https://doi.org/10.1038/s41598-026-37962-5

Download citation

  • Received: 23 July 2025

  • Accepted: 28 January 2026

  • Published: 21 February 2026

  • DOI: https://doi.org/10.1038/s41598-026-37962-5

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Falcarindiol
  • Asthma
  • Nrf2 pathway
  • Airway inflammation
  • Oxidative stress
  • Airway remodeling
Download PDF

Advertisement

Explore content

  • Research articles
  • News & Comment
  • Collections
  • Subjects
  • Follow us on Facebook
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • About Scientific Reports
  • Contact
  • Journal policies
  • Guide to referees
  • Calls for Papers
  • Editor's Choice
  • Journal highlights
  • Open Access Fees and Funding

Publish with us

  • For authors
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Scientific Reports (Sci Rep)

ISSN 2045-2322 (online)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research